Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	MET Activating Mutations in Tumor Tissue	12	28
Total, all-cause mortality	MET Gene Amplifications in Tumor Tissue	14	20
Total, all-cause mortality	MET Activating Mutations in ctDNA	3	8
Total, all-cause mortality	MET Gene Amplifications in ctDNA	9	12
Total, all-cause mortality	Total	38	68
Total, other adverse events	MET Activating Mutations in Tumor Tissue	28	28
Total, other adverse events	MET Gene Amplifications in Tumor Tissue	20	20
Total, other adverse events	MET Activating Mutations in ctDNA	7	8
Total, other adverse events	MET Gene Amplifications in ctDNA	12	12
Total, other adverse events	Total	67	68
Total, serious adverse events	MET Activating Mutations in Tumor Tissue	12	28
Total, serious adverse events	MET Gene Amplifications in Tumor Tissue	10	20
Total, serious adverse events	MET Activating Mutations in ctDNA	4	8
Total, serious adverse events	MET Gene Amplifications in ctDNA	7	12
Total, serious adverse events	Total	33	68

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02544633/event-totals